• LAST PRICE
    16.1200
  • TODAY'S CHANGE (%)
    Trending Down-0.1600 (-0.9828%)
  • Bid / Lots
    16.1000/ 1
  • Ask / Lots
    17.4400/ 1
  • Open / Previous Close
    17.2300 / 16.2800
  • Day Range
    Low 16.0300
    High 17.2900
  • 52 Week Range
    Low 12.9500
    High 25.4700
  • Volume
    560,498
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 16.28
TimeVolumeRCUS
09:32 ET1498317.14
09:34 ET1404616.92
09:36 ET1234716.71
09:38 ET732216.83
09:39 ET1210016.73
09:41 ET50016.81
09:43 ET60016.795
09:45 ET95716.65
09:48 ET173416.77
09:50 ET40016.7307
09:52 ET380016.5556
09:54 ET10016.56
09:56 ET217216.45
09:57 ET188216.33
09:59 ET120816.37
10:01 ET320816.31
10:03 ET383416.32
10:06 ET338816.54
10:08 ET267516.56
10:10 ET120016.58
10:12 ET20016.605
10:14 ET141816.54
10:15 ET10016.58
10:19 ET230516.41
10:21 ET120016.39
10:24 ET20016.4199
10:26 ET42716.44
10:28 ET212716.38
10:30 ET30016.39
10:32 ET198416.405
10:33 ET40916.47
10:39 ET106516.53
10:44 ET20016.505
10:48 ET229716.61
10:50 ET30016.58
10:51 ET133016.57
10:53 ET50116.65
10:55 ET55216.605
10:57 ET110016.6075
11:00 ET90016.6
11:04 ET110016.62
11:06 ET46216.645
11:08 ET163316.67
11:09 ET787116.69
11:11 ET100016.71
11:13 ET52616.74
11:15 ET10016.75
11:18 ET611716.65
11:20 ET430216.59
11:22 ET30416.56
11:24 ET209216.635
11:26 ET486516.65
11:27 ET10016.65
11:29 ET10016.65
11:31 ET62616.665
11:33 ET198716.615
11:36 ET748616.6
11:38 ET49916.57
11:40 ET30016.56
11:44 ET50016.525
11:45 ET33916.52
11:49 ET50016.485
11:51 ET132716.42
11:54 ET56816.36
11:56 ET30416.38
12:00 ET10016.375
12:02 ET40016.3547
12:03 ET20016.345
12:05 ET70016.335
12:07 ET140316.38
12:09 ET40316.36
12:12 ET139716.32
12:16 ET286516.36
12:20 ET58416.38
12:21 ET23316.365
12:23 ET10016.38
12:25 ET30016.39
12:27 ET33416.4
12:30 ET129616.38
12:32 ET51216.38
12:34 ET10016.37
12:36 ET80016.33
12:38 ET20016.33
12:39 ET60016.3699
12:41 ET20016.36
12:43 ET20016.38
12:45 ET242716.47
12:48 ET552316.39
12:50 ET110016.41
12:56 ET160016.39
12:59 ET70016.32
01:01 ET316216.31
01:06 ET10016.3
01:10 ET305416.28
01:12 ET52616.3
01:14 ET267216.31
01:17 ET60016.32
01:19 ET90716.325
01:21 ET152916.3
01:26 ET202716.25
01:28 ET60216.26
01:32 ET85516.28
01:33 ET168316.24
01:35 ET70016.2
01:37 ET110016.2
01:46 ET127716.17
01:48 ET146116.18
01:50 ET10016.19
01:51 ET184316.19
01:53 ET47516.22
01:57 ET72116.24
02:00 ET60016.23
02:02 ET349216.16
02:04 ET140316.14
02:08 ET168516.13
02:13 ET10016.125
02:15 ET10016.125
02:18 ET28416.14
02:20 ET10016.135
02:24 ET39116.1243
02:26 ET149716.1
02:27 ET24516.105
02:29 ET39916.08
02:31 ET30016.075
02:33 ET92516.1
02:36 ET30016.09
02:38 ET140016.07
02:42 ET387216.11
02:44 ET59016.135
02:45 ET100016.11
02:47 ET50116.13
02:49 ET55716.12
02:51 ET107816.1
02:54 ET70516.09
03:02 ET10016.05
03:03 ET428916.05
03:05 ET103816.09
03:07 ET10016.085
03:09 ET173016.09
03:14 ET30016.0992
03:16 ET51616.11
03:18 ET122416.161
03:20 ET30016.1401
03:21 ET30016.16
03:23 ET196516.13
03:27 ET193416.11
03:30 ET32716.1
03:32 ET110616.105
03:34 ET40016.105
03:36 ET150016.08
03:38 ET140016.06
03:39 ET259816.06
03:41 ET290416.04
03:43 ET282316.11
03:45 ET253616.165
03:48 ET603416.09
03:50 ET614316.06
03:52 ET238116.13
03:54 ET522516.14
03:56 ET358116.115
03:57 ET978516.12
03:59 ET14239816.12
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRCUS
Arcus Biosciences Inc
1.5B
-5.2x
---
United StatesARDX
Ardelyx Inc
1.6B
-23.4x
---
United StatesVIR
Vir Biotechnology Inc
1.4B
-2.6x
---
United StatesXNCR
Xencor Inc
1.5B
-10.8x
---
United StatesGYRE
Gyre Therapeutics Inc
1.0B
-6.4x
---
United StatesIMTX
Immatics NV
1.2B
-11.1x
---
As of 2024-05-26

Company Information

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.

Contact Information

Headquarters
3928 Point Eden WayHAYWARD, CA, United States 94545-3719
Phone
510-694-6200
Fax
302-730-1370

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Terry Rosen
President, Co-Founder
Juan Jaen
Chief Financial Officer
Robert Goeltz
Chief Operating Officer
Jennifer Jarrett
Chief Accounting Officer
Alexander Azoy

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.5B
Revenue (TTM)
$237.0M
Shares Outstanding
91.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.86
EPS
$-3.10
Book Value
$6.12
P/E Ratio
-5.2x
Price/Sales (TTM)
6.2
Price/Cash Flow (TTM)
---
Operating Margin
-113.92%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.